One possible mechanism of action of E3 ubiquitin ligases UBR1 and UBR2 could be to facilitate targeting of foldable conformers to the proteasome [39] and to provide protection against toxicity of (unknown) misfolded proteins that accumulate during the disease course in lymphocytes from ALS patients. Here, UBR2 is linked to amyotrophic lateral sclerosis.